vs
ASCENT INDUSTRIES CO.（ACNT）与BALCHEM CORP（BCPC）财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是ASCENT INDUSTRIES CO.的22.2倍（$263.6M vs $11.9M）。BALCHEM CORP净利率更高（14.9% vs -8.8%，领先23.6%）。ASCENT INDUSTRIES CO.同比增速更快（13.3% vs 9.8%）。过去两年BALCHEM CORP的营收复合增速更高（4.9% vs -34.9%）
阿森特工业（股票代码ACNT）前身为拆分自探索控股公司的独立上市媒体企业阿森特传媒，后转型为公开上市控股公司，核心子公司为莫尼特罗尼克斯，主营依托子公司开展安防相关业务运营。
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
ACNT vs BCPC — 直观对比
营收规模更大
BCPC
是对方的22.2倍
$11.9M
营收增速更快
ACNT
高出3.5%
9.8%
净利率更高
BCPC
高出23.6%
-8.8%
两年增速更快
BCPC
近两年复合增速
-34.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $11.9M | $263.6M |
| 净利润 | $-1.0M | $39.2M |
| 毛利率 | 14.6% | 35.6% |
| 营业利润率 | -21.0% | 19.8% |
| 净利率 | -8.8% | 14.9% |
| 营收同比 | 13.3% | 9.8% |
| 净利润同比 | -1.2% | 16.8% |
| 每股收益（稀释后） | $-0.11 | $1.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACNTBCPC
| Q4 25 | $11.9M | $263.6M | ||
| Q3 25 | $19.7M | $267.6M | ||
| Q2 25 | $18.7M | $255.5M | ||
| Q1 25 | $24.7M | $250.5M | ||
| Q4 24 | $10.5M | $240.0M | ||
| Q3 24 | $20.9M | $239.9M | ||
| Q2 24 | $21.5M | $234.1M | ||
| Q1 24 | $28.0M | $239.7M |
净利润ACNTBCPC
| Q4 25 | $-1.0M | $39.2M | ||
| Q3 25 | $-2.1M | $40.3M | ||
| Q2 25 | $6.3M | $38.3M | ||
| Q1 25 | $-2.3M | $37.1M | ||
| Q4 24 | $-1.0M | $33.6M | ||
| Q3 24 | $-6.2M | $33.8M | ||
| Q2 24 | $-926.0K | $32.1M | ||
| Q1 24 | $-5.5M | $29.0M |
毛利率ACNTBCPC
| Q4 25 | 14.6% | 35.6% | ||
| Q3 25 | 29.7% | 35.7% | ||
| Q2 25 | 26.1% | 36.4% | ||
| Q1 25 | 19.3% | 35.2% | ||
| Q4 24 | 24.3% | 36.0% | ||
| Q3 24 | 14.4% | 35.6% | ||
| Q2 24 | 13.1% | 35.5% | ||
| Q1 24 | 8.3% | 34.0% |
营业利润率ACNTBCPC
| Q4 25 | -21.0% | 19.8% | ||
| Q3 25 | -4.1% | 20.4% | ||
| Q2 25 | -14.4% | 20.1% | ||
| Q1 25 | -4.2% | 20.4% | ||
| Q4 24 | -25.4% | 19.8% | ||
| Q3 24 | -9.4% | 20.0% | ||
| Q2 24 | -8.6% | 19.6% | ||
| Q1 24 | -15.5% | 17.4% |
净利率ACNTBCPC
| Q4 25 | -8.8% | 14.9% | ||
| Q3 25 | -10.6% | 15.1% | ||
| Q2 25 | 33.7% | 15.0% | ||
| Q1 25 | -9.3% | 14.8% | ||
| Q4 24 | -9.8% | 14.0% | ||
| Q3 24 | -29.5% | 14.1% | ||
| Q2 24 | -4.3% | 13.7% | ||
| Q1 24 | -19.7% | 12.1% |
每股收益（稀释后）ACNTBCPC
| Q4 25 | $-0.11 | $1.21 | ||
| Q3 25 | $-0.22 | $1.24 | ||
| Q2 25 | $0.65 | $1.17 | ||
| Q1 25 | $-0.23 | $1.13 | ||
| Q4 24 | $-0.11 | $1.03 | ||
| Q3 24 | $-0.61 | $1.03 | ||
| Q2 24 | $-0.09 | $0.98 | ||
| Q1 24 | $-0.54 | $0.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $57.6M | $74.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $87.0M | $1.3B |
| 总资产 | $111.9M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACNTBCPC
| Q4 25 | $57.6M | $74.6M | ||
| Q3 25 | $58.0M | $65.1M | ||
| Q2 25 | $60.5M | $65.4M | ||
| Q1 25 | $14.3M | $49.9M | ||
| Q4 24 | $16.1M | $49.5M | ||
| Q3 24 | $8.5M | $73.7M | ||
| Q2 24 | $3.6M | $63.7M | ||
| Q1 24 | $1.3M | $60.3M |
总债务ACNTBCPC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ACNTBCPC
| Q4 25 | $87.0M | $1.3B | ||
| Q3 25 | $87.1M | $1.3B | ||
| Q2 25 | $89.7M | $1.3B | ||
| Q1 25 | $91.2M | $1.2B | ||
| Q4 24 | $93.5M | $1.1B | ||
| Q3 24 | $94.7M | $1.2B | ||
| Q2 24 | $101.0M | $1.1B | ||
| Q1 24 | $102.0M | $1.1B |
总资产ACNTBCPC
| Q4 25 | $111.9M | $1.7B | ||
| Q3 25 | $119.9M | $1.7B | ||
| Q2 25 | $122.6M | $1.7B | ||
| Q1 25 | $152.5M | $1.6B | ||
| Q4 24 | $147.3M | $1.6B | ||
| Q3 24 | $148.6M | $1.6B | ||
| Q2 24 | $158.2M | $1.6B | ||
| Q1 24 | $161.0M | $1.6B |
负债/权益比ACNTBCPC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $266.0K | $67.3M |
| 自由现金流经营现金流 - 资本支出 | $-196.0K | — |
| 自由现金流率自由现金流/营收 | -1.7% | — |
| 资本支出强度资本支出/营收 | 3.9% | — |
| 现金转化率经营现金流/净利润 | — | 1.72× |
| 过去12个月自由现金流最近4个季度 | $-2.1M | — |
8季度趋势，按日历期对齐
经营现金流ACNTBCPC
| Q4 25 | $266.0K | $67.3M | ||
| Q3 25 | $1.3M | $65.6M | ||
| Q2 25 | $-1.4M | $47.3M | ||
| Q1 25 | $-700.0K | $36.5M | ||
| Q4 24 | $8.8M | $52.3M | ||
| Q3 24 | $3.4M | $51.3M | ||
| Q2 24 | $2.2M | $45.0M | ||
| Q1 24 | $263.0K | $33.4M |
自由现金流ACNTBCPC
| Q4 25 | $-196.0K | — | ||
| Q3 25 | $695.0K | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-1.0M | — | ||
| Q4 24 | $8.4M | — | ||
| Q3 24 | $3.1M | — | ||
| Q2 24 | $1.9M | — | ||
| Q1 24 | $25.0K | — |
自由现金流率ACNTBCPC
| Q4 25 | -1.7% | — | ||
| Q3 25 | 3.5% | — | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -4.1% | — | ||
| Q4 24 | 80.6% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 9.1% | — | ||
| Q1 24 | 0.1% | — |
资本支出强度ACNTBCPC
| Q4 25 | 3.9% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 0.9% | — |
现金转化率ACNTBCPC
| Q4 25 | — | 1.72× | ||
| Q3 25 | — | 1.63× | ||
| Q2 25 | -0.22× | 1.23× | ||
| Q1 25 | — | 0.98× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 1.52× | ||
| Q2 24 | — | 1.40× | ||
| Q1 24 | — | 1.15× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACNT
暂无分部数据
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
